Mismatch Repair (MMR) Protein Expression is Uncommon in Poorly Differentiated Neuroendocrine Carcinoma

被引：0
|
作者：
Hadoux, J. [1 ]
Malka, D. [2 ]
Berdeloux, A. [1 ]
Planchard, D. [2 ]
Boige, V [2 ]
Hescot, S. [1 ]
Burtin, P. [2 ]
Leboulleux, S. [1 ]
Ducreux, M. [2 ]
Baudin, E. [1 ]
Scoazec, J. Y. [3 ]
机构：
[1] Gustave Roussy, Endocrine Oncol & Nucl Med, Villejuif, France
[2] Gustave Roussy, Med Oncol, Villejuif, France
[3] Gustave Roussy, Pathol, Villejuif, France
来源：
NEUROENDOCRINOLOGY | 2017年 / 105卷
关键词：
neuroendocrine carcinoma; mismatch repair; microsatellite instability;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H4
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [41] Correlation of clinicopathologic features and expression of mismatch repair (MMR) protein and p53 protein in endometrial adenocarcinomas
    Kim, KR
    Jun, SY
    Kang, GH
    Shim, YH
    MODERN PATHOLOGY, 2001, 14 (01) : 138A - 138A
  • [42] Expression of nuclear and mitochondrial mismatch repair genes (MMR) in colorectal carcinoma: A study of North Indian population
    Yadav, Alka
    Jain, Mayank
    Kumar, Ashok
    Kumari, Niraj
    Krishnani, Narendra
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 : 107 - 107
  • [43] PD-L1, Mismatch Repair Protein, and NTRK Immunohistochemical Expression in Cervical Small Cell Neuroendocrine Carcinoma
    Chen, Longyun
    Yang, Fan
    Feng, Ting
    Wu, Shafei
    Li, Kaimi
    Pang, Junyi
    Shi, Xiaohua
    Liang, Zhiyong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [44] Salvage Chemotherapy by FOLFIRI Regimen for Poorly Differentiated Gastrointestinal Neuroendocrine Carcinoma
    Sugiyama, Keiji
    Shiraishi, Kazuhiro
    Sato, Mariko
    Nishibori, Riko
    Nozawa, Kazuki
    Kitagawa, Chiyoe
    JOURNAL OF GASTROINTESTINAL CANCER, 2021, 52 (03) : 947 - 951
  • [45] Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma
    Wang, Haihong
    Lin, Zhenyu
    Li, Guiling
    Zhang, Dejun
    Yu, Dandan
    Lin, Qili
    Wang, Jing
    Zhao, Ye
    Pi, Guoliang
    Zhang, Tao
    BMC CANCER, 2020, 20 (01)
  • [46] Poorly Differentiated Large Cell Neuroendocrine Carcinoma of the Colon: A Case Report
    Felux, Kelsee
    McCarty, Burke
    Turner, Dennis
    Gray, TKeyah
    Patel, Vijaykumar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [47] Salvage Chemotherapy by FOLFIRI Regimen for Poorly Differentiated Gastrointestinal Neuroendocrine Carcinoma
    Keiji Sugiyama
    Kazuhiro Shiraishi
    Mariko Sato
    Riko Nishibori
    Kazuki Nozawa
    Chiyoe Kitagawa
    Journal of Gastrointestinal Cancer, 2021, 52 : 947 - 951
  • [48] Late Recurrence of a Seminoma of the Testis With a Poorly Differentiated Neuroendocrine Carcinoma Component
    Elena Thai
    Leonardi, Francesco
    Soliani, Paolo
    Silini, Enrico Maria
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2012, 20 (04) : 396 - 400
  • [49] Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma
    Haihong Wang
    Zhenyu Lin
    Guiling Li
    Dejun Zhang
    Dandan Yu
    Qili Lin
    Jing Wang
    Ye Zhao
    Guoliang Pi
    Tao Zhang
    BMC Cancer, 20
  • [50] Paclitaxel, carboplatin, and etoposide (TCE) in advanced poorly differentiated neuroendocrine carcinoma
    Loeffler, Luisa Mantovani
    Mauersberger, Elias
    Weimann, Arved
    Kuerschner, Dorit
    Schimmelpfennig, Christoph
    Wiechmann, Volker
    Bisanz, Heike
    Zeissig, Gisela
    Zeynalova, Samira
    Schmoll, Hans-Joachim
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345